Bioavailability enhancement

CurcuVail® offers superior, clinically proven curcumin bioavailability for diverse applications like beverages and health foods. It's tasteless, odorless, water-dispersible, pesticide-free, and non-GMO. Backed by studies for respiratory, joint, and liver health, its GRAS status ensures safety. Elevat...

Our drug product pre-formulation and formulation development services can also includes in vivo PK studies, conducted with multiple animal species and a rapid turnaround time. This additional service further extends our full suite offering to our clients while eliminating the need for additional vendor sou...

Hyaluronidase, an enzyme that breaks down hyaluronic acid, has long been used to facilitate the dispersion and absorption of other drugs and to reduce tissue damage in cases of extravasation of a drug. Recombinant human hyaluronidase (rhPH20) developed by BaoPharma is the only...

Dispersome®️ – A green technology for drugs

The Dispersome® technology uses high quality whey protein, an environmentally friendly by-product from cheese production, to improve the solubility and bioavailability of poorly soluble drugs.

To watch explanatory Dispersome...

The depth of our bioavailability (BA) enhancement offering makes us a leader in addressing addressing low solubility, low bioavailability and dissolution rate issues. We work collaboratively with our customers to advance compounds, or re-purpose existing compounds, across a full range of API properties and...

Your benefits
- choice between aqueous or organic solution                                       ...

Hydroxypropyl cellulose (HPC) is a semisynthetic, water-soluble cellulose derivative widely used in the pharmaceutical industry because of its excellent film-forming, thickening, and stabilizing properties.

With a fully integrated, unified approach from pre-formulation development to GMP manufacturing, we help maximise drug product potential by enhancing solubility, stability and therapeutic effect.

cavitron™ cyclodextrins (hydroxypropyl betacyclodextrin) are the perfect substances for increasing solubility and enhancing bioavailability. They are manufactured to high purity standards for low bioburden and endotoxin.
To learn more visit https://www.ashland.com/industries/pharmaceutical/oral-...

Inhaled drug products for nasal or pulmonary delivery continue in popularity due to the prevalence of respiratory diseases around the globe. Additionally, the lung’s absorptive capacity continues to be explored as an attractive delivery point for both local and systemic applications. Particle engineering, ...

The selection of a lead solid form of an API is a critical step in early pharmaceutical development. Determining the most suitable chemical and physical form impacts a range of critical parameters including manufacturability, stability and bioavailability. The selection of a lead solid involves the screeni...

FGF 2 is a non-glycosylated, heparin-binding protein with a molecular mass of 17.25 kDa. It is a member of the FGF family. It exhibits wide-ranging angiogenic and mitogenic properties. Engineered for enhanced thermal stability, this variant retains full biological activity even under extended exposur...

EGF (epidermal growth factor) is a non-glycosylated protein with a molecular mass of 6.2 kDa. It's a member of the EGF family and is a potent mitogen. EGF's primary functions include stimulating cell growth, proliferation, and differentiation, making it crucial for processes like wound healing and ti...

PRODUCT

Nutraceutical designed to support conventional therapies for osteoporosis treatment

The only clinicaly tested nutraceutical formulation with proven pro-osteogenic action

INNOVATIVE FEATURES
• High bioavai...

The KinetiSol Technology generates amorphous solid dispersions, dramatically improving the bioavailability of poorly soluble drugs. KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies, in a fraction of the time of other ASD technologies. With its significantly smal...

NanoCBD is a formulation containing 16.67 mg/mL cannabidiol (CBD) as active ingredient, in a sub-micron spray applied to the oro-buccal membrane. The CBD is sourced from cannabis (hemp) strains and extracted from plant parts that produce high levels of CBD, but no THC.

IP RIGHTS:
Paten...

MultiBiotic™ is an evidence-based multi-species probiotic specifically designed to target end-organ function and support gastrointestinal health and maintenance. MultiBiotic™ is an ARTG listed medicine and available in Pharmacies and HCP's in AU, NZ, SG and HK. Presently MultiBiotic™ is in Phase ...

NanaBidial™ is an investigative new product containing 20 mg/mL of Cannabidiol (CBD) and and <1mg/mL of delta-9-tetrahydrocannabinol (THC), in a sub-micron spray applied to the oro-buccal membrane.
CLINICAL TRIAL:
The buccal administration of a NanoCelle™ CBD preparation to healthy volunteers:...